Chargeurs SA
PAR:CRI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chargeurs SA
PAR:CRI
|
FR |
|
A
|
Ashtead Group PLC
OTC:ASHTF
|
UK |
|
PainReform Ltd
NASDAQ:PRFX
|
IL |
|
V
|
Vonovia SE
DUS:VNA
|
DE |
|
Mcphy Energy SA
F:M6P
|
FR |
|
Marin Software Inc
NASDAQ:MRIN
|
US |
|
Passage Bio Inc
NASDAQ:PASG
|
US |
|
Tokyo Century Corp
TSE:8439
|
JP |
|
Ajinomoto Co Inc
OTC:AJINY
|
JP |
|
B
|
Baidu Inc
OTC:BAIDF
|
CN |
|
T
|
Troax Group AB (publ)
F:5TOA
|
SE |
|
Noxopharm Ltd
ASX:NOX
|
AU |
|
CDW Corp
NASDAQ:CDW
|
US |
|
N
|
Novonix Ltd
NASDAQ:NVX
|
AU |
|
Treasure Global Inc
NASDAQ:TGL
|
US |
|
mBank SA
LSE:0DU3
|
PL |
Wall St Price Targets
CRI Price Targets Summary
Chargeurs SA
According to Wall Street analysts, the average 1-year price target for CRI is 11.73 EUR with a low forecast of 10.61 EUR and a high forecast of 13.65 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRI's stock price target?
Price Target
11.73
EUR
According to Wall Street analysts, the average 1-year price target for CRI is 11.73 EUR with a low forecast of 10.61 EUR and a high forecast of 13.65 EUR.
What is the Revenue forecast for Chargeurs SA?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Chargeurs SA?
Projected CAGR
332%
Over the last 14 years, the compound annual growth rate for Operating Income has been -14%. The projected CAGR for the next 2 years is 332%.
